TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$19.99 USD
-0.59 (-2.87%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $20.05 +0.06 (0.30%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.01 |
EPS Last Quarter | 0.04 |
Last EPS Surprise | 200.00% |
ABR | 1.63 |
Earnings ESP
|
100.00% |
---|---|
Current Year | -0.01 |
Next Year | 0.63 |
EPS (TTM) | 0.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 77.12M | 91.25M | 297.98M | 442.75M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 79.70M | 92.31M | 301.30M | 511.40M |
Low Estimate | 74.90M | 89.80M | 293.30M | 296.01M |
Year ago Sales | 165.82M | 43.97M | 233.66M | 297.98M |
Year over Year Growth Est. | -53.49% | 107.53% | 27.52% | 48.59% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.01 | 0.03 | -0.01 | 0.63 |
# of Estimates | 4 | 4 | 7 | 6 |
Most Recent Consensus | -0.03 | 0.00 | -0.09 | 0.67 |
High Estimate | 0.02 | 0.08 | 0.45 | 1.02 |
Low Estimate | -0.06 | -0.05 | -0.23 | 0.11 |
Year ago EPS | 0.73 | -0.09 | 0.09 | -0.01 |
Year over Year Growth Est. | -101.37% | 133.33% | -111.11% | 6,461.87% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.01 | 0.03 | -0.01 | 0.63 |
7 Days Ago | -0.01 | 0.03 | -0.01 | 0.63 |
30 Days Ago | -0.01 | 0.03 | -0.01 | 0.64 |
60 Days Ago | -0.01 | 0.03 | -0.01 | 0.64 |
90 Days Ago | -0.01 | 0.03 | -0.01 | 0.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.00 | 0.03 | -0.09 | 0.67 |
Zacks Consensus Estimate | -0.01 | 0.03 | -0.01 | 0.63 |
Earnings ESP | 100.00% | 0.00% | -600.01% | 5.79% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.04 | -0.07 | -0.09 | 0.73 | NA |
Estimate | -0.04 | -0.03 | -0.12 | 0.29 | NA |
Difference | 0.08 | -0.04 | 0.03 | 0.44 | 0.13 |
Surprise | 200.00% | -133.33% | 25.00% | 151.72% | 60.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more